Effectiveness and safety of sodium-glucose cotransporter-2 inhibitor initiation in sacubitril-valsartan users with heart failure: a population-based cohort study.

Saved in:
Bibliographic Details
Title: Effectiveness and safety of sodium-glucose cotransporter-2 inhibitor initiation in sacubitril-valsartan users with heart failure: a population-based cohort study.
Authors: Wu CY; Department of Pharmacology and Toxicology, University of Toronto, 777 Bay Street, Toronto, Ontario M5G 2R3, Canada.; Dr. Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada., Shah BR; Division of Endocrinology, Department of Medicine, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada.; Department of Medicine, Temerty Faculty of Medicine, University of Toronto, 6 Queen's Park Crescent West, Toronto, Ontario M5S 3H2, Canada.; ICES, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada., Ezekowitz JA; Mazankowski Alberta Heart Institute, University of Alberta, 11220 83 Avenue, Edmonton, Alberta T6G 2B7, Canada.; Canadian VIGOUR Centre, University of Alberta, 4-120 Katz Group Centre for Pharmacy and Health Research, Edmonton, Alberta T6G 2E1, Canada., Sharma A; Division of Cardiology, McGill University Health Centre, McGill University, 1001 Boulevard Décarie, Montreal, Quebec H4A 3J1, Canada.; DREAM-CV Lab, McGill University Health Centre, McGill University, 1001 Boulevard Décarie, Montreal, Quebec H4A 3J1, Canada., Wang T; ICES, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada., Wu CF; ICES, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada., Liu PP; University of Ottawa Heart Institute, University of Ottawa, 40 Ruskin Street, Ottawa, Ontario K1Y 4W7, Canada., Edwards JD; University of Ottawa Heart Institute, University of Ottawa, 40 Ruskin Street, Ottawa, Ontario K1Y 4W7, Canada.; School of Epidemiology and Public Health, University of Ottawa, 600 Peter Morand Crescent, Ottawa, Ontario K1G 5Z3, Canada.; ICES uOttawa, 1053 Carlind Avenue, Ottawa, Ontario K1Y 4E9, Canada., Swardfager W; Department of Pharmacology and Toxicology, University of Toronto, 777 Bay Street, Toronto, Ontario M5G 2R3, Canada.; Dr. Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada.; KITE University Health Network Toronto Rehabilitation Institute, 347 Rumsey Road, Toronto, Ontario M4G 1R7, Canada.
Source: European heart journal. Cardiovascular pharmacotherapy [Eur Heart J Cardiovasc Pharmacother] 2026 Jul 14; Vol. 12 (4), pp. 269-281.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101669491 Publication Model: Print Cited Medium: Internet ISSN: 2055-6845 (Electronic) NLM ISO Abbreviation: Eur Heart J Cardiovasc Pharmacother Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2055-6845
DOI:10.1093/ehjcvp/pvag031